
No. of Pages: 115 | Report Code: TIPRE00022179 | Category: Life Sciences
No. of Pages: 115 | Report Code: TIPRE00022179 | Category: Life Sciences
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America miRNA Sequencing and Assay Market – By Product
1.3.2 North America miRNA Sequencing and Assay Market – By Technology
1.3.3 North America miRNA Sequencing and Assay Market – By End User
1.3.4 North America miRNA Sequencing and Assay Market – By Country
2. miRNA Sequencing and Assay Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America miRNA Sequencing and Assay – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.3 Expert Opinions
5. miRNA Sequencing and Assay Market – Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Widening Range of MicroRNA Applications
5.1.2 Rise in Funding for Genomics Research
5.2 Market Restraints
5.2.1 Challenges Related to Delivery, Efficacy, and Specificity of miRNA-based Therapeutics
5.3 Market Opportunities
5.3.1 Rising Prevalence of Chronic Conditions and Infectious Diseases
5.4 Future Trends
5.4.1 Development and Launch of Innovative Products
5.5 Impact analysis
6. miRNA Sequencing and Assay Market – North America Analysis
6.1 North America miRNA Sequencing and Assay Market Revenue Forecast and Analysis
7. miRNA Sequencing and Assay Market Analysis – By Product
7.1 Overview
7.2 miRNA Sequencing and Assay Market Revenue Share, by Product (2019 and 2027)
7.3 Library Preparation
7.3.1 Overview
7.3.2 Library Preparation: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Consumables
7.4.1 Overview
7.4.2 Consumables: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
8. miRNA Sequencing and Assay Market Analysis – By Technology
8.1 Overview
8.2 miRNA Sequencing and Assay Market Share, by Technology, 2019 and 2027, (%)
8.3 Sequencing by Synthesis
8.3.1 Overview
8.3.2 Sequencing by Synthesis: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Nanopore
8.4.1 Overview
8.4.2 Nanopore: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Ion Semiconductor Sequencing
8.5.1 Overview
8.5.2 Ion Semiconductor Sequencing: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
9. miRNA Sequencing and Assay Market Analysis – By End User
9.1 Overview
9.2 miRNA Sequencing and Assay Market Share, by End User, 2019 and 2027, (%)
9.3 Research Institute
9.3.1 Overview
9.3.2 Research Institute: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Academia
9.4.1 Overview
9.4.2 Academia: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
9.5 Contract Research Organizations (CROs)
9.5.1 Overview
9.5.2 Contract Research Organizations (CROs): miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
10. miRNA Sequencing and Assay Market – North America Analysis
10.1 North America: miRNA Sequencing and Assay Market
10.1.1 Overview
10.1.2 North America: miRNA Sequencing and Assay Market, by Country, 2019 & 2027 (%)
10.1.3 US: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
10.1.3.1 US: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
10.1.3.2 US: miRNA Sequencing and Assay Market, by Product, 2018–2027 (USD Million)
10.1.3.3 US: miRNA Sequencing and Assay Market, by Technology, 2018–2027 (USD Million)
10.1.3.4 US: miRNA Sequencing and Assay Market, by End User, 2018–2027 (USD Million)
10.1.4 Canada: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
10.1.4.1 Canada: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
10.1.4.2 Canada: miRNA Sequencing and Assay Market, by Product, 2018–2027 (USD Million)
10.1.4.3 Canada miRNA Sequencing and Assay Market, by Technology, 2018–2027 (USD Million)
10.1.4.4 Canada: miRNA Sequencing and Assay Market, by End User, 2018–2027 (USD Million)
10.1.5 Mexico: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
10.1.5.1 Mexico: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
10.1.5.2 Mexico: miRNA Sequencing and Assay Market, by Product, 2018–2027 (USD Million)
10.1.5.3 Mexico: miRNA Sequencing and Assay Market, by Technology, 2018–2027 (USD Million)
10.1.5.4 Mexico: miRNA Sequencing and Assay Market, by End User, 2018–2027 (USD Million)
11. Impact of COVID-19 Pandemic on North America miRNA Sequencing and Assay Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 Illumina, Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 THERMO FISHER SCIENTIFIC INC.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 QIAGEN
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Perkin Elmer, Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Takara Bio Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 New England Biolabs
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Norgen Biotek Corp
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 TriLink BioTechnologies Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Lexogen GmbH
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Oxford Nanopore Technologies
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. US miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 2. US miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 3. US miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 4. Canada miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 5. Canada miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 6. Canada miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 7. Mexico miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 8. Mexico miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 9. Mexico miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 10. Organic Developments Done by Companies
Table 11. Inorganic Developments Done by Companies
Table 12. Glossary of Terms, miRNA Sequencing and Assay Market
LIST OF FIGURES
Figure 1. miRNA Sequencing and Assay Market Segmentation
Figure 2. miRNA Sequencing and Assay Market Segmentation, By Country
Figure 3. miRNA Sequencing and Assay Market Overview
Figure 4. Library Preparation Segment by Product Segment Expected to Witness Rapid Growth
Figure 5. North America miRNA Sequencing and Assay Market – Leading Country Markets (US$ Million)
Figure 6. North America PEST Analysis
Figure 7. miRNA Sequencing and Assay Market Impact Analysis of Driver and Restraints
Figure 8. North America miRNA Sequencing and Assay Market – Revenue Forecast and Analysis – 2019- 2027
Figure 9. miRNA Sequencing and Assay Market Revenue Share, by Product (2019 and 2027)
Figure 10. Library Preparation: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
Figure 11. Consumables: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
Figure 12. miRNA Sequencing and Assay Market Share, by Technology, 2019 and 2027 (%)
Figure 13. Sequencing by Synthesis: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
Figure 14. Nanopore: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
Figure 15. Ion Semiconductor Sequencing: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
Figure 16. miRNA Sequencing and Assay Market Share, by End User, 2019 and 2027 (%)
Figure 17. Research Institute: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
Figure 18. Academia: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
Figure 19. Contract Research Organizations (CROs): miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. North America: miRNA Sequencing and Assay Market, by Key Country – Revenue (2019) (USD Million)
Figure 21. North America: miRNA Sequencing and Assay Market, by Country, 2019 & 2027 (%)
Figure 22. US: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
Figure 23. Canada: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
Figure 24. Mexico: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
Figure 25. Impact of COVID-19 Pandemic in North American Country Markets